Leadership

Marty Landon

Chief Executive Officer, BioBridge Global

Martin “Marty” J. Landon has 30 years of experience in the health care industry. Landon has held senior positions in public and private companies and is recognized for building and leading high-performance teams and value-creating initiatives. In 2016, he joined BioBridge Global as chief executive officer. Landon serves on the board of the San Antonio Medical Foundation and as secretary/treasurer on the board of BioMed SA.

Landon began his career as an internal auditor at the University of Texas Health Science Center at San Antonio and later was an auditor for four years at public accounting firm Arthur Andersen & Co. In 1987, Landon joined lntelogic Trace, a NYSE-traded firm, where he was appointed chief financial officer.

From 1994 to 2012, Landon was an executive at Kinetic Concepts Inc., now Acelity, a global medical device company, where he led numerous acquisitions, financial and securities transactions. He developed major process improvements and IT initiatives that contributed to extraordinary growth, culminating in a $6.3 billion leveraged buyout. During his tenure at KCI, annual revenues increased from $250 million to nearly $2 billion.

Prior to his current role, Landon served as president and CEO of CeloNova BioSciences Inc., an early-stage, innovative medical device company that develops, manufactures and sells products with multiple vascular applications. Landon remains a member of the CeloNova board of directors.

Landon was a Certified Public Accountant from 1984 to 2010 and received his BA in accounting from Benedictine College in Kansas. Landon is a member of the advisory council of SAMMinistries in San Antonio, Texas, chair of the UTSA Research External Advisory Council and a member of the board of visitors at Southwestern University in Georgetown, Texas. He also serves as Chairman of the Board of Renovo Concepts Inc.

Read more

Rachel-Louise Beddard, MD

Senior Vice President, Chief Medical Officer

Dr. Beddard joined South Texas Blood & Tissue Center as the VP, Medical Affairs on August 2007. Prior to joining our organization, she worked for Johns Hopkins University as an Immunology Laboratory Research Associate, Tidewater Blood Research Laboratory, as the Medical Director, and Texas Cord Blood Bank, as the Medical Director.

Dr. Beddard received her undergraduate degree from the University of Virginia and her graduate degree from Eastern Virginia Medical School. She has licensures from Virginia, Texas, Georgia, and New York. She is also board certified in Clinical Pathology and Transfusion Medicine.

Read more

Granville C. Betton

Senior Vice President, Talent & Performance Management

Granville has 30 years of experience in operations, manufacturing, services, quality, safety, and process improvement and has successfully guided teams across multiple global locations, driven revenue growth and ensured excellence in service delivery.

After graduating from Rensselaer Polytechnic Institute with a Bachelor of Science in Chemical Engineering, he worked for DuPont in Delaware and Mississippi before joining GE in 1990. He spent the next 24 years in GE working in its Plastics, Medical Systems, and Silicones businesses. He held many positions with GE of increasing complexity and responsibility. In 2014 he moved to Houston TX where he worked for Nexeo Solutions, InterWrap, Inc. and Gulf Coast Regional Blood Center before joining BioBridge Global in October 2017.

Read more

Becky Butler Cap

Senior Vice President, Chief Operating Officer, GenCure

Becky Cap, a 25-year veteran of the life sciences industry, was named chief operating officer of San Antonio-based GenCure in February 2016. GenCure, a subsidiary of BioBridge Global, is focused on providing process development and cGMP manufacturing services. Cap drove the intra-preneurial development and integration of these new service lines for BioBridge Global and supported the extension of other business unit offerings into the cell therapy and regenerative medicine space. GenCure’s mission is to realize the potential of donated human cells and tissue to save and enhance lives.

Cap, a native of Texas, earned a bachelor’s degree from Harvard University and an MBA from Boston University’s Questrom School of Management. She began her career at Dana-Farber Cancer Institute in Boston, where she worked on early trials exploring the benefits of hematologic stem cell transplant for breast cancer and the effects of growth factors in high-dose chemotherapy trials.

Her move to industry began at Eidetics, a consulting firm focused on informing biomedical product development support. She supported US and global development and strategic marketing efforts for chemotherapeutics, leading monoclonal antibodies, tyrosine kinase inhibitors and immuno-oncology agents, including PD-1 and PDL-1 inhibitors. Her expertise was honed as Oncology became an active and competitive market in which physicians and patients had multiple treatment options available to them for their cancers. She started one of the first Oncology Consulting Practices in this strategic marketing and market research space. She also has run her own consulting firm and worked with a number of local startups in the San Antonio community.

Cap has provided strategic guidance for the development of pharmaceuticals and medical devices, both in large, established firms and early stage ventures. She has provided extensive entrepreneurial executive coaching and mentoring. She is an active member of local and national committees on Regenerative Medicine and Cell Therapy, two private company Boards of Directors and the Governing Committee for Seton Home. Additionally, Cap is a co-founder and founding president of San Antonio TechBoosters, a 501(c)6 organization established to mentor student entrepreneurs.

Read more

Ward Carter

Senior Vice President, BioBridge Global, and Chief Commerical Officer

Ward Carter, who has been with the organization for five years, brings more than 31 years of experience with Abbott Laboratories to his role in leading sales, marketing and customer relationship management for BioBridge Global.

At Abbott Laboratories, Carter was responsible for managing sales and service teams supporting transfusion medicine in the United States and was responsible for implementing new commercial sales and marketing processes specific to customer contract and pricing development, along with ongoing customer contract and entitlement management. He also was directly involved in development of commercial compliance initiatives, including customer reporting processes and new ethics and compliance guidelines specifically for all Abbott Diagnostics commercial organizations.

During his five years as Chief Operating Officer of QualTex Laboratories, Carter led a complete computer system change and integration, two facility redesigns and renovations, and the implementation of laboratory automation systems in both Atlanta and San Antonio. Carter has been instrumental in expanding the capacity footprint and introducing new products and services that expand the customer service offering, while at the same time ensuring that quality is core to everything the QualTex Laboratories team delivers. With facilities in San Antonio and Atlanta, QualTex Laboratories is one of the largest independent nonprofit biologic testing centers in the United States. QualTex Laboratories provides testing services for blood, plasma and tissue donations, as well as advanced testing to support cellular therapy and cell manufacturing, in addition to reference testing and clinical research testing support.

Read more

Mark Fite

Senior Vice President, BioBridge Global and Chief Operating Officer, QualTex Laboratories

Mark Fite joined BioBridge Global in July 2020 and has been Chief Operating Officer for QualTex Laboratories since June 2021. He brings more than 30 years of wide-ranging operations experience from a variety of biomedical and pharmaceutical organizations.

Fite’s most recent role was as Chief Operating Officer at Pharmaceutical Associate Inc., a generic liquid oral dose manufacturer focused on producing generic oral dose liquid bioequivalent formulations for children, adults and the elderly who may have swallowing disorders or restricted diets. Prior to that, Fite worked for 14 years for DPT Laboratories, a San Antonio-based CDMO. During his tenure at DPT as Senior Vice President for Operations, he was the project leader for multiple high-impact projects that allowed DPT to grow into a premier CDMO provider.

After graduating from Appalachian State University, Fite started his career at international health and beauty aid company Revlon, and then moved on to other management roles in the United States and the United Kingdom before joining DPT.

Read more

Glenn Kues

Senior Vice President and Chief Financial Officer

Glenn Kues joined BioBridge Global in December 2017. Glenn has over 35 years of experience in finance, operations, and technology. Most recently, Glenn was Chief Financial Officer for San Antonio based Renaissance Pharmaceuticals/DPT Laboratories, an integrated pharmaceutical company with both proprietary products and CDMO services. Glenn was with Renaissance/DPT 21 years and held responsibilities for finance, legal, information technology and purchasing.

After graduating from Trinity University with a Bachelor of Science, degree in Computer Science and Accounting Glenn began his career with the international accounting firm KPMG. He has also worked for three privately held contract-manufacturing companies as well as a private holding company. Glenn is a San Antonio native and has had the good fortune of spending the majority of his life in our great city.

Read more

Elizabeth Waltman

Senior Vice President, Chief Operating Officer, South Texas Blood & Tissue Center

Elizabeth Waltman joined the organization in January, 2013. Waltman manages all areas of blood operations, including the departments of donor services, donor recruitment, product management, component laboratory, hospital services and operations integration, as well as the Victoria facility.

With over 17 years of experience in executive management, Waltman has previously held positions in recruitment, quality assurance, corporate communications and project management. Most recently, she has worked in management roles with Blood Systems, Inc. and was previously with Gulf Coast Regional Blood Center. She began her career in the health care industry as a nurse in labor and delivery.

Waltman has a Masters in Business Administration from the University of Phoenix and a Bachelor of Arts from University of St. Thomas. She is the South Central Association of Blood Banks (SCABB) Foundation Treasurer and is an active member in the American College of Healthcare Executives, the American Blood Bank Society as well as other professional health care organizations.

Read more

William "Richey" Wyatt

Senior Vice President, General Counsel, & Chief Compliance Officer

Richey Wyatt has an extensive legal background, first as a corporate attorney with the law firm Strasburger & Price, LLP (formerly Oppenheimer, Blend, Harrison and Tate, Inc.), where he was a partner and subsequently as Sr. Vice President and General Counsel for a group of health care related entrepreneurial ventures.

Richey received his undergraduate degree from Vanderbilt University (double majoring in English & Philosophy) and his law degree, with honors, from the University of Houston Law Center. Richey is very involved in the San Antonio community having served on various community and non-profit boards as well as in Leadership San Antonio (a leadership program jointly sponsored by the San Antonio Chamber of Commerce & the San Antonio Hispanic Chamber of Commerce). Currently, Richey services on the boards of the San Antonio Museum of Art and a youth soccer club. Richey is married to Joan and has two sons, Henry & Taylor.

Read more